[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”2_3″ spacing=’yes’ last=’no’ background_color=” background_image=” background_repeat=’no-repeat’
background_position=’left top’ border_size=’0px’ border_color=” border_style=’solid’ padding=” class=” id=”]

News5050 – Company Report

April 11, 2017

[/fusion_builder_column][fusion_builder_column type=”1_3″ spacing=’yes’ last=’yes’ background_color=” background_image=” background_repeat=’no-repeat’ background_position=’left top’ border_size=’0px’ border_color=” border_style=’solid’ padding=” class=” id=”][fusion_button link=’https://www.researchandexperts.com/Israel/life-sciences/report/05IC-GDPH408689D/’ color=’orange’ size=’large’ type=’flat’ shape=’pill’ target=’_blank’ title=’Kadimastem Ltd (KDST) – Pharmaceuticals & Healthcare – Deals and…’ gradient_colors=’|’ gradient_hover_colors=’|’ accent_color=” accent_hover_color=” bevel_color=” border_width=’1px’ shadow=” icon=’fa-search’ icon_divider=’yes’ icon_position=’left’ modal=” animation_type=’0′ animation_direction=’down’ animation_speed=’0.1′ alignment=’left’ class=” id=”]View report[/fusion_button][/fusion_builder_column]

The Report:

Kadimastem Ltd (Kadimastem) is a biotechnology company that develops and commercializes stem cell-based therapeutics for diabetes and neurodegenerative disorders. The company offers human pluripotent stem cell technology, based on differentiation of human embryonic stem cells towards insulin producing beta cells, and glucagon producing alpha cells arranged in islet-like clusters. Its technology is a combination of purification capabilities with a specific differentiation process of the islet-like clusters. The company’s technology differentiates human pluripotent cells into mature oligodendrocytes, astrocytes, motoneurons, pancreatic beta cells and other cell types. Kadimastem is headquartered in Nes-Ziona, Israel.

Scope

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Life Sciences and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000287377[/fusion_builder_row][/fusion_builder_container]